E - bonitete

ACIES BIO, biotehnološke raziskave in razvoj, d.o.o.

Company: ACIES BIO, biotehnološke raziskave in razvoj, d.o.o.
Address: Tehnološki park 21, 1000 LJUBLJANA

Google maps
Municipality: Ljubljana
Region: Central Slovenia (Osrednjeslovenska)
Contacts: 00386 59075995
Štefan Fujs
Company management: Director: Štefan Fujs, tel.: 00386 59075990,
Director: Branko Drobnak
Director: Enej Kuščer
Extract of management responsible for a company's business operations abroad: Štefan Fujs,
Registration number: 2226391
Tax number: 38270692
Organisational form: Limited Liability Company
Source of capital: Mixed
Number of employees: 89
Size of company: Medium-sized
Income: 8.678.830,00 €
Exports share in income: 99,00 %
Tradition since: 2006
Total equity: 13.264.139,00 €
Total assets: 16.725.489,00 €
Extract of target regions and countries where a company exports: Austria
Description of company: ACIES BIO is a biotechnology research SME, established in 2006 and active primarily in the field of pharmaceutical, environmental and food biotechnology. The key areas of research are microbiology and metabolic and biosynthetic engineering of secondary metabolite production, yield improvement and bioprocess development, as well as genetic / metabolic engineering of microbial strains, aided by systems biology approaches of genomics, transcriptomics and proteomics. ACIES BIO has an established track record of strain improvement and process development collaborations with leading international pharmaceutical and food companies in Europe and Asia, a number of smaller biotech companies and academic collaborators. ACIES BIO was recognized for its excellence and was named Slovenian Start-up of the year in 2008, and is a co-founding member of the Slovenian Center of Excellence in the field of life-sciences (CIPKEBIP, 2009) and the Slovenian Competence Center in the Food and Health sector (KCBRIN,2011), supported by the Slovenian Ministry of Education.
Description of products and services: ACIES BIO has full capacity and expertise to carry out strain improvement and fermentation process development and optimization up to pilot-scale for the most ambitious and technologically demanding projects and has in the past successfully carried out entire fermentation technology development projects for leading European and international pharmaceutical companies.
Classification of company:
Main activity in accordance with the NACE classification
72.110 R&D on biotechnology
Activities in accordance with the CPA classification
72.11.11 Research and experimental development services in health biotechnology
Field of activity: Services
Credit rating information:
EXCELLENT credit ratingOrder credit report
Credit rating information provided by EBONITETE.SI
Information on the presentation card companies are obtained from surveys. Financial data are for the financial year 2023, last update 22.05.2024.
Last data update 13.06.2024.